Julie Smith

CIK 1557928 · President and CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.54M

Companies

4

Total Filings

35

Lifetime Open-Market Net

-$8.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STOK Director $29.82 $0 7 2026-06-05
EXEL Director 28,957 $53.13 $1.54M -$8.07M 16 2026-05-29
BOLD Director $1.41 $0 5 2020-01-15
Raptor Pharmaceutical Corp (RPTP) Delisted President and CEO 64,179 $0 7 2016-10-26

Recent Filings · Page 3 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-02-08 BOLD Grant (A) $0 EDGAR
2018-06-08 BOLD Grant (A) $0 EDGAR
2018-05-24 EXEL Grant (A) $0 EDGAR
2017-10-10 BOLD Grant (A) $0 EDGAR
2017-05-26 EXEL Grant (A) $0 EDGAR
2017-02-24 EXEL Grant (A) $0 EDGAR
2017-01-05 BOLD Grant (A) $0 EDGAR
2016-10-26 Raptor Pharmaceutical Corp (RPTP) Delisted Mixed −109,938 -$989.4K EDGAR
2016-09-26 EXEL Grant (A) +763 $0 EDGAR
2016-02-11 Raptor Pharmaceutical Corp (RPTP) Delisted Grant (A) +64,179 $0 EDGAR
Showing 2130 of 35
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.